Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
178,300,846
-
Total 13F shares
-
61,892,616
-
Share change
-
-455,853
-
Total reported value
-
$163,922,000
-
Price per share
-
$2.65
-
Number of holders
-
31
-
Value change
-
+$665,885
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of Compass Therapeutics, Inc. - Common Stock (CMPX) as of Q2 2022
As of 30 Jun 2022,
Compass Therapeutics, Inc. - Common Stock (CMPX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,892,616 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, Rock Springs Capital Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Foresite Capital Management V, LLC, JANUS HENDERSON GROUP PLC, CHI Advisors LLC, Avidity Partners Management LP, Vivo Capital, LLC, and Consonance Capital Management LP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.